Generic Drug Therapeutic Class: Diagnostic Products or Other Therapeutic Products
active ingredients: Borax + Boric acid
Lab: Johnson & Johnson Sante Bea

Solution for ophthalmic lavage
in single dose container box of 10 5 ml single dose containers
All forms


Wash the eye in case of irritation.

Dosage DACRYUM solution for ophthalmic lavage in single-dose container box of 10 5 ml single-dose containers

Wash the eye in case of irritation.

Against indications

Hypersensitivity to boric acid, borax or any of the excipients listed under Composition .

Dacryum side effects

Adverse effects identified during clinical trials and after marketing with DACRYUM, solution for ophthalmic lavage in single-dose containers are listed in the organ systems in order of frequency in the table below according to the following convention:

Very frequent (≥1 / 10); Frequent (≥ 1/100, <1/10); not very frequent (≥ 1/1000, <1/100); rare (≥ 1/10000, <1/1000); very rare (<1/10000); undefined frequency (can not be estimated on the basis of available data).

Class of organ systems

Frà © quence

Undesirable effect

Eye disorders


Eye irritation.

Declaration of suspected untoward effects

The declaration of suspected adverse effects after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals disclose any suspected adverse effects via the national reporting system: National Agency for Drug and Health Product Safety (ANSM) and network Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts